BridgeBio Pharma (NASDAQ:BBIO) Price Target Raised to $52.00
BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price target hoisted by Scotiabank from $49.00 to $52.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a sector outperform rating on the stock. Several other brokerages also recently weighed in on BBIO. Evercore ISI upped their price objective on BridgeBio […]
BridgeBio Pharma (NASDAQ:BBIO – Free Report) had its price target hoisted by Scotiabank from $49.00 to $52.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has a sector outperform rating on the stock. Several other brokerages also recently weighed in on BBIO. Evercore ISI upped their price objective on BridgeBio […]
